
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies : The OVERCOME Trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted
Keywords: CMR، رزونانس مغزی قلب; cardiac toxicity; carvedilol; chemotherapy; enalapril; left ventricular dysfunction; preventionACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CMR, cardiac magnetic resonance; HSCT, hematopoietic stem-cell transplantat